News · Bispecific Antibody
285 stories
Jun 5, 26Pharma is betting big on PD-1/VEGF bispecifics. But are companies chasing the wrong target?
May 30, 26STAT+: BioNTech and Pfizer tout bispecifics data at ASCO, and Pazdur sees silver lining at FDA
May 13, 26Dr Loghavi on the Significance of Updated WHO Diagnostic Criteria for AML in Clinical Practice
May 13, 26Patient Selection for Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer